These Ebola Researchers Are Stuck in US Due to Trump’s Funding Cuts | WIREDSkip to main contentMenuSECURITYPOLITICSTHE BIG STORYBUSINESSSCIENCECULTUREREVIEWSMenuAccountAccountNewslettersSecurityPoliticsThe Big StoryBusinessScienceCultureReviewsChevronMoreExpandThe Big InterviewMagazineEventsWIRED InsiderWIRED ConsultingNewslettersPodcastsVideoLivestreamsMerchSearchSearchEmily MullinScienceMay 28, 2026 6:30 AMThese Researchers Would Be in Africa Fighting Ebola—but Trump Cut Their FundingThe Centers for Research in Emerging Infectious Diseases were launched during the Covid-19 pandemic. The group lost its funding under Trump in part due to conspiracy theories.Photograph: Roberto Schmidt/Getty ImagesCommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyAs the world struggles to contain the rapidly growing Ebola outbreak in the Democratic Republic of Congo’s Ituri province, a vital network of research centers has been unable to help on the ground. The reason: The Trump administration slashed its funding last year, in part due to conspiracy theories about the origins of Covid-19.Established in 2020 by the National Institutes of Health, the Centers for Research in Emerging Infectious Diseases (CREID) Network was conducting research into viruses that emerge from wildlife and spill over to people, including the family of viruses that Ebola belongs to. The network operated 10 sites around the world where these types of disease outbreaks are likely to occur, including in Central and East Africa. (The network was also researching hantavirus, a disease that saw a recent rare outbreak on a cruise ship.)NIH provided CREID with approximately $82 million in funding over five years, and its funding was up for renewal in 2025. But last June, the centers received a stop-work order stating that their research had been deemed “unsafe for Americans and not a good use of taxpayer funding,” and that the agency’s priorities no longer supported the network.“That reason is pretty rich, right? Because that was really the kind of pandemic preparedness research that we need to do,” says Kristian Andersen, an evolutionary virologist at Scripps Research in La Jolla, California, who led one of the two CREID centers in West Africa. Andersen was involved in developing diagnostics and conducted genomic sequencing of Ebola virus genomes during past outbreaks to learn how the virus was evolving and spreading. He doesn’t have NIH funding to do that kind of work now.He says he is talking to colleagues in the DRC and reviewing data about the outbreak, but isn’t able to offer support with testing or sequencing. “We sit here in San Diego and see this unfold,” he says."The whole network would have mobilized," says Robert Garry, a professor of microbiology and immunology at Tulane Medical School, who led the center with Andersen.The CREID centers were involved in developing reagents and diagnostic tests, which have been lacking on the ground in the DRC. Public health agencies failed to spot early infections because the tests used were designed to detect the more common Zaire strain of Ebola, which was responsible for previous outbreaks in the DRC. The current outbreak is caused by the Bundibugyo virus.CREID was likely a target because of its loose connections to the Covid-19 lab-leak theory espoused by President Donald Trump and Republican lawmakers. One of its original centers was run by the EcoHealth Alliance, a former US nonprofit that became a flashpoint in conspiracy theories over the origins of Covid-19 because of its ties to the Wuhan Institute of Virology. Under Trump, the Department of Health and Human Services permanently barred EcoHealth Alliance from receiving taxpayer dollars in January 2025. The White House also cited EcoHealth’s connections to the Wuhan lab as a reason for dissolving the US Agency for International Development.Neither the HHS nor the White House responded to a request for comment.Andersen’s center in West Africa was focused on Ebola virus and Lassa virus. Another CREID site in Nairobi, Kenya, focused on other infectious diseases, but it played a key role in responding to a September 2022 Ebola outbreak in Uganda. And its former leader says it would have been part of the response this time around, and would have drawn on research from other centers in the network.“We had active studies there. We were covering Eastern and Central Africa. We would have been there,” says M. Kariuki Njenga, a virologist at Washington State University who led the CREID center in Eastern and Central Africa.CREID centers worked with local collaborators to boost disease surveillance and provide support for outbreak investigations. During the 2022 outbreak, rapid detection of cases and effective contact tracing led to Uganda declaring the outbreak over just four months after it began.In total, 164 people were infected and 55 died as a result of that outbreak. The current outbreak is already responsible for at least 1,000 suspected cases and 238 suspected deaths in the DRC, with seven confirmed cases, including one death, in neighboring Uganda.Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, has expressed concern over the speed at which the outbreak is growing. “We are urgently scaling up operations,” he said this week during an online meeting of the African Union, “but at the moment the epidemic is outpacing us.”CommentsBack to topTriangleYou Might Also LikeHow to find us: Add WIRED.com to your preferred sources in GoogleHow the Canvas hack threatened thousands of schoolsBig Story: I've covered robots for years—this one is eerily lifelikeOrbs, saucers, and flashes on the moon—here’s what’s in the UFO filesTake our survey: What does “home” mean to you?Emily Mullin is a staff writer at WIRED, covering biotechnology. Previously, she was an MIT Knight Science Journalism project fellow and a staff writer covering biotechnology at Medium's OneZero. Before that, she served as an associate editor at MIT Technology Review, where she wrote about biomedicine. Her stories have also ... Read MoreStaff WriterXTopicsEbolaDonald Trumpinfectious diseaseAfricadiseasespublic healthRead More‘Perfect Storm’: How Trump’s Aid Cuts Are Fueling the Ebola OutbreakOne health provider who works on the ground says that basic medical equipment like masks and hand sanitizers are in short supply due to funding cuts.Kate KnibbsA New Hantavirus Vaccine Is in the WorksSince 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.Javier CarbajalInside the Race to Develop a Test for the Rare Andes HantavirusA University of Nebraska lab has developed a test that can detect the virus before symptoms become severe. Now, it's ready to start testing those returning to the US after a cruise outbreak.Emily MullinVenom and Hot Peppers Offer a Key to Killing Resistant BacteriaResearchers have developed three new antibiotics from scorpion venom and habanero peppers to combat tuberculosis and other drug-resistant pathogens.Fernanda GonzálezHere’s What You Need to Know About the HantavirusWhile the outbreak aboard a cruise ship in the Atlantic is concerning, the virus isn’t easily transmitted through casual contact.Emily MullinWe Now Know How Many People the CDC Is Monitoring for HantavirusThere are no confirmed cases in the US, but 41 people who were potentially exposed to the Andes virus are in quarantine or being monitored for symptoms.Emily MullinA Danish Couple’s Maverick African Research Finds Its Moment in RFK Jr.’s Vaccine PolicyThe work of Peter Aaby and Christine Stabell Benn has long been controversial. Until Robert F. Kennedy Jr. became US health policy chief, most vaccine scientists tended to ignore it. Now they can’t.Arthur Allen, KFF Health NewsHow AI Could Help Combat Antibiotic ResistanceAt WIRED Health, British surgeon Ara Darzi said AI is set to transform the diagnosis and treatment of drug-resistant infections. But a lack of incentives means innovation may not reach patients.Emily MullinHow Wet Weather in Argentina Helped Fuel the Cruise Ship Hantavirus OutbreakClimate change is helping create conditions that are driving the rodent boom—dubbed a ratada—in Argentina.María de los Ángeles OrfilaMeet Rassvet, Russia’s Answer to StarlinkWith the launch of the first 16 satellites, Russia begins construction of a network for satellite internet that aims to cover the entire country by 2030. But getting there won’t be easy.Lucia BellinelloHantavirus Conspiracy Theories Are Already Spreading OnlineFrom claims of an Israeli false flag to efforts to sell ivermectin, influencers and grifters are using lessons learned from Covid-19 to push their baseless conspiracy theories.David GilbertSupercharging Immune Cells May Help Control HIV Long-TermCAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV.Emily MullinWIRED is obsessed with what comes next. Through rigorous investigations and game-changing reporting, we tell stories that don’t just reflect the moment—they help create it. When you look back in 10, 20, even 50 years, WIRED will be the publication that led the story of the present, mapped the people, products, and ideas defining it, and explained how those forces forged the future. WIRED: For Future Reference.More From WIREDSubscribeNewslettersLivestreamsTravelFAQWIRED StaffWIRED EducationEditorial StandardsArchiveRSSSite MapAccessibility HelpReviews and GuidesReviewsBuying GuidesStreaming GuidesWearablesCouponsGift GuidesAdvertiseContact UsManage AccountJobsPress CenterCondé Nast StoreUser AgreementPrivacy PolicyYour California Privacy Rights© 2026 Condé Nast. All rights reserved. WIRED may earn a portion of sales from products that are purchased through our site as part of our Affiliate Partnerships with retailers. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Condé Nast. Ad ChoicesSelect international siteUnited StatesLargeChevronItaliaJapónCzech Republic & SlovakiaFacebookXPinterestYouTubeInstagramTiktok

The Centers for Research in Emerging Infectious Diseases (CREID) Network, established by the National Institutes of Health in 2020, was dedicated to researching viruses that emerge from wildlife and spill over into human populations, including the family of viruses that Ebola belongs to. This international network operated ten sites globally, operating in regions where these disease outbreaks are likely to occur, such as Central and East Africa, and also researched other related pathogens like hantavirus. The network received approximately $82 million in funding from the NIH over five years, which was up for renewal in 2025. However, the network faced a significant disruption when the Trump administration slashed this funding, partly due to conspiracy theories surrounding the origins of COVID-19.

The research centers received a stop-work order, with the administration deeming their work "unsafe for Americans and not a good use of taxpayer funding" because the agency's priorities no longer supported the network. This decision directly impeded critical pandemic preparedness research. Researchers, such as Kristian Andersen, an evolutionary virologist who led one of the CREID centers in West Africa and was involved in genomic sequencing of Ebola virus genomes during past outbreaks, lost the necessary funding to conduct essential work. Andersen noted that he was unable to provide support with testing or sequencing, despite being on the front lines observing the unfolding crisis in the Democratic Republic of Congo.

The CREID centers were instrumental in developing reagents and diagnostic tests which were lacking on the ground in the Democratic Republic of Congo. Furthermore, the research focused on understanding virus evolution and transmission. Public health agencies struggled to respond effectively because the tests utilized were designed for the more common Zaire strain of Ebola, whereas the current outbreak in the region was caused by the Bundibugyo virus, highlighting a critical gap in diagnostic preparedness.

The CREID network was likely targeted due to its connections to theories surrounding the COVID-19 lab-leak hypothesis, specifically through its affiliation with the EcoHealth Alliance, a former nonprofit that became a focal point for conspiracy theories. Consequently, the Department of Health and Human Services permanently barred the EcoHealth Alliance from receiving taxpayer dollars in January 2025, and the White House cited these connections as a reason for dissolving the US Agency for International Development. This political action meant that centers and personnel, like M. Kariuki Njenga, who led a center in Eastern and Central Africa, would have been positioned to mobilize support during Ebola outbreaks, as they had active research and local collaborations for disease surveillance and investigation.

Ultimately, the disruption to the CREID network limited the capacity to respond effectively to emerging infectious diseases. While the network’s work, including rapid detection and contact tracing during the 2022 Ebola outbreak in Uganda, successfully contained that specific event, the political decisions undermined the capacity for proactive, broad-based research necessary to manage the rapidly growing threat of current outbreaks, such as the one in the DRC, where the epidemic is already responsible for thousands of suspected cases and deaths.